Source:http://linkedlifedata.com/resource/pubmed/id/17642930
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2007-7-23
|
pubmed:abstractText |
Dexamethasone-cyclophosphamide pulse (DCP) therapy for the pemphigus group of disorders is being widely used in India after its introduction in 1986. However, there are certain limitations to its application due to the serious side effects of cyclophosphamide.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:issn |
0973-3922
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
329-33
|
pubmed:articleTitle |
Pulse therapy and its modifications in pemphigus: a six year study.
|
pubmed:affiliation |
Department of Dermatology, Osmania Medical College, Hyderabad.
|
pubmed:publicationType |
Journal Article
|